Predictors of cardiomyopathy development in patients undergoing high-dose immunosuppressive therapy and autologous hematopoietic stem cell transplantation
https://doi.org/10.24884/1609-2201-2026-105-2-88-91
About the Authors
V. A. ShurakovaRussian Federation
Vera A. Shurakova, Assistant of the Department of Propaedeutics of Internal Diseases with the Clinic named after Academician M. D. Tushinsky
6–8 L'va Tolstogo St., Saint Petersburg, 197022
A. N. Kulikov
Russian Federation
Alexander N. Kulikov, Dr. of Sci. (Med.), Professor, Head of the Department of Propaedeutics of Internal Diseases with the Clinic named after Academician M. D. Tushinsky, Head of the Department of Functional Diagnostics, Director of the Scientific and Clinical Research Center
Saint Petersburg
A. Yu. Polushin
Russian Federation
Aleksey Yu. Polushin, Cand. of Sci. (Med.), Head of the Scientific and Clinical Center for Transplantation and Cell Therapy for Autoimmune and Neurodegenerative Diseases
Saint Petersburg
Yu. R. Zalyalov
Russian Federation
Yuriy R. Zalyalov, Cand. of Sci. (Med.), Head of the Department of Chemotherapy and Hematopoietic Stem Cell Transplantation for Oncologic and Autoimmune Diseases
Saint Petersburg
E. I. Lopatina
Russian Federation
Evgeniya I. Lopatina, Neurologist at the Scientific and Clinical Center for Transplantation and Cell Therapy for Autoimmune and Neurodegenerative Diseases
Saint Petersburg
A. A. Tsynchenko
Russian Federation
Aleksandr A. Tsynchenko, Hematologist at the Scientific and Clinical Center for Transplantation and Cell Therapy for Autoimmune and Neurodegenerative Diseases
Saint Petersburg
Review
For citations:
Shurakova V.A., Kulikov A.N., Polushin A.Yu., Zalyalov Yu.R., Lopatina E.I., Tsynchenko A.A. Predictors of cardiomyopathy development in patients undergoing high-dose immunosuppressive therapy and autologous hematopoietic stem cell transplantation. New St. Petersburg Medical Records. 2026;(2):88-91. (In Russ.) https://doi.org/10.24884/1609-2201-2026-105-2-88-91
JATS XML
